Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells.
par Flourakis, Matthieu;Lehen'kyi, V'yacheslav;Beck, Benjamin 
;Raphael, Maylis ;Vandenberghe, M;Abeele, F V;Roudbaraki, Morad;Lepage, G;Mauroy, B;Romanin, C;Shuba, Yaroslav;Skryma, Roman;Prevarskaya, Natalia
Référence Cell death & disease, 1, page (e75)
Publication Publié, 2010-09
;Raphael, Maylis ;Vandenberghe, M;Abeele, F V;Roudbaraki, Morad;Lepage, G;Mauroy, B;Romanin, C;Shuba, Yaroslav;Skryma, Roman;Prevarskaya, NataliaRéférence Cell death & disease, 1, page (e75)
Publication Publié, 2010-09
Article révisé par les pairs
| Titre: |
|
| Auteur: | Flourakis, Matthieu; Lehen'kyi, V'yacheslav; Beck, Benjamin; Raphael, Maylis; Vandenberghe, M; Abeele, F V; Roudbaraki, Morad; Lepage, G; Mauroy, B; Romanin, C; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia |
| Informations sur la publication: | Cell death & disease, 1, page (e75) |
| Statut de publication: | Publié, 2010-09 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Amino Acid Substitution |
| Antineoplastic Agents -- therapeutic use | |
| Apoptosis | |
| Calcium -- metabolism | |
| Calcium Channels -- genetics -- metabolism -- physiology | |
| Cell Line, Tumor | |
| Cisplatin -- therapeutic use | |
| Humans | |
| Male | |
| Membrane Proteins -- metabolism | |
| Mutation | |
| Neoplasm Proteins -- metabolism | |
| ORAI1 Protein | |
| Phenotype | |
| Prostatic Neoplasms -- drug therapy -- metabolism | |
| Stromal Interaction Molecule 1 | |
| Thapsigargin -- therapeutic use | |
| Tumor Necrosis Factor-alpha -- therapeutic use | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:E230326 |
| info:doi/10.1038/cddis.2010.52 | |
| info:pii/cddis201052 | |
| info:pmid/21364678 | |
| PMC3032347 |
